Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:1345:55-66.
doi: 10.1007/978-1-4939-2978-8_4.

Detection of Helical Intermediates During Amyloid Formation by Intrinsically Disordered Polypeptides and Proteins

Affiliations

Detection of Helical Intermediates During Amyloid Formation by Intrinsically Disordered Polypeptides and Proteins

Andisheh Abedini et al. Methods Mol Biol. 2016.

Abstract

Amyloid formation and aberrant protein aggregation are hallmarks of more than 30 different human diseases. The proteins that form amyloid can be divided into two structural classes: those that form compact, well-ordered, globular structures in their unaggregated state and those that are intrinsically disordered in their unaggregated states. The latter include the Aβ peptide of Alzheimer's disease, islet amyloid polypeptide (IAPP, amylin) implicated in type 2 diabetes and α-synuclein, which is linked to Parkinson's disease. Work in the last 10 years has highlighted the potential role of pre-amyloid intermediates in cytotoxicity and has focused attention on their properties. A number of intrinsically disordered proteins appear to form helical intermediates during amyloid formation. We discuss the spectroscopic methods employed to detect and characterize helical intermediates in homogenous solution and in membrane-catalyzed amyloid formation, with the emphasis on the application of circular dichroism (CD). IAPP is used as an example, but the methods are generally applicable.

Keywords: Amylin; Amyloid; Aβ; CD; Helical intermediate; Islet amyloid polypeptide; Oligomer.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Selkoe DJ. Cell biology of protein misfolding: The examples of Alzheimer's and Parkinson's diseases. Nat Cell Biol. 2004;6:1054–1061. - PubMed
    1. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006;75:333–366. - PubMed
    1. Sipe JD. Amyloidosis. Crit Rev Clin Lab Sci. 1994;31:325–354. - PubMed
    1. Westermark P, Andersson A, Westermark GT. Islet amyloid polypeptide, islet amyloid, and diabetes mellitus. Physiol Rev. 2011;91:795–826. - PubMed
    1. Abedini A, Raleigh DP. A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides. Protein Eng Design & Select. 2009;22:453–459. - PMC - PubMed

Publication types

MeSH terms

Substances